Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126173692 | 12617369 | 2 | F | 20160626 | 20160916 | 20160803 | 20160922 | EXP | GB-MHRA-EYC 00142776 | GB-UCBSA-2016028501 | UCB | 60.00 | YR | M | Y | 0.00000 | 20160922 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126173692 | 12617369 | 1 | PS | KEPPRA | LEVETIRACETAM | 1 | UNK | U | U | 21035 | |||||||||
126173692 | 12617369 | 2 | I | MELOXICAM. | MELOXICAM | 1 | Oral | 7.5 MG, UNK | Y | U | 0 | 7.5 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126173692 | 12617369 | 1 | Seizure |
126173692 | 12617369 | 2 | Joint injury |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126173692 | 12617369 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126173692 | 12617369 | Generalised tonic-clonic seizure | |
126173692 | 12617369 | Inhibitory drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126173692 | 12617369 | 2 | 20160608 | 20160626 | 0 |